Skip to main content
Michael Ohl, MD, Infectious Disease, Iowa City, IA

MichaelEOhlMD

Infectious Disease Iowa City, IA

Assistant Professor, Internal Medicine, University of Iowa College of Medicine

Dr. Ohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ohl's full profile

Already have an account?

  • Office

    200 Hawkins Dr
    Iowa City, IA 52242
    Phone+1 319-356-7740
    Fax+1 319-384-7208

Education & Training

  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Family Medicine, 2003 - 2004
  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 1999 - 2002
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • IA State Medical License
    IA State Medical License 2006 - 2026
  • WA State Medical License
    WA State Medical License 1999 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • University of Iowa Led Observational Study Reveals Remdesivir Can Lengthen Hospital Stay & Not Contribute to Survival
    University of Iowa Led Observational Study Reveals Remdesivir Can Lengthen Hospital Stay & Not Contribute to SurvivalJuly 21st, 2021
  • Remdesivir Treatment Plan Kept COVID-19 Patients Hospitalized Longer, University of Iowa Research Shows
    Remdesivir Treatment Plan Kept COVID-19 Patients Hospitalized Longer, University of Iowa Research ShowsJuly 21st, 2021
  • Remdesivir Treatment Period for COVID-19 Patients Kept Hospital Beds Full While They Were Scarce
    Remdesivir Treatment Period for COVID-19 Patients Kept Hospital Beds Full While They Were ScarceJuly 20th, 2021
  • Join now to see all